NOTCH3 and breast cancer: Taken together, these findings revealed the critical role of NOTCH3 oncogenic signaling in the genesis of breast cancer metastases and provided a compelling preclinical rationale for the design of novel therapeutic strategies that will selectively target the NOTCH3 signaling pathway to improve the clinical outcome of patients with advanced breast cancer.